Section Arrow
QGEN.NYSE
- Qiagen NV
Quotes are at least 15-min delayed:2026/02/24 06:34 EST
Pre Market
Last
 47.42
-0.03 (-0.06%)
Bid
47.46
Ask
47.5
High 47.43 
Low 47.35 
Volume 60 
Regular Hours (Closed)
Last
 47.45
-1.12 (-2.31%)
Day High 
48.08 
Prev. Close
48.57 
1-M High
56.19 
Volume 
15.33K 
Bid
47.46
Ask
47.5
Day Low
47.37 
Open
47.87 
1-M Low
47.96 
Market Cap 
10.01B 
Currency 美元 
P/E 24.93 
%Yield 5.63 
10-SMA 49.98 
20-SMA 51.61 
50-SMA 49.85 
52-W High 57.815 
52-W Low 39.610526 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
1.95/3.02
Enterprise Value
11.35B
Balance Sheet
Book Value Per Share
18.33
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
1.97B
Operating Revenue Per Share
9.48
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BLLNBilliontoone Inc72.31-13.11-15.35%-- 
Pre Market -- -- --
ADVBAdvanced Biomed Inc.4.13+0.13+3.25%22.83PE
Pre Market 4.2 +0.07 +1.69%
ISPCiSpecimen Inc0.2449-0.0343-12.29%-- 
Pre Market 0.239 -0.0059 -2.41%
MBAICheck-Cap Ltd.1.57-0.08-4.85%-- 
Pre Market -- -- --
OPKOPKO Health1.15-0.05-4.17%-- 
Pre Market 1.15 0 0.00%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.